Tarsus Pharmaceuticals, Inc. Contracts & Agreements

31 Contracts & Agreements
Browse by Contract Category
Contracts
Category
Company
Industry
Jur. Jurisdiction
Filed
Underwriting Agreement, dated February 29, 2024, by and among the Company, Goldman Sachs & Co. LLC, BofA Securities, Inc. and Guggenheim Securities, LLC
Underwriting Agreements
Tarsus Pharmaceuticals, Inc.
2024
Form of Pre-Funded Warrant
Warrant Agreements
Tarsus Pharmaceuticals, Inc.
2024
Second Amendment to Loan and Security Agreement, dated as of August 28, 2023, by and among Registrant, Hercules Capital, Inc. and First-Citizens Bank & Trust Company
Loan Agreements
Tarsus Pharmaceuticals, Inc.
2023
Separation Agreement, dated May 4, 2023, by and between Registrant and Leonard Greenstein
Separation Agreements
Tarsus Pharmaceuticals, Inc.
2023
Underwriting Agreement, dated August 1, 2023, by and among the Company, Goldman Sachs & Co. LLC, BofA Securities, Inc. and Guggenheim Securities, LLC
Underwriting Agreements
Tarsus Pharmaceuticals, Inc.
2023
Amended and
Tarsus Pharmaceuticals, Inc.
2022
Amended and Restated License Agreement, dated June 3, 2022, by and between the Registrant and Elanco Tiergesundheit AG
License Agreements
Tarsus Pharmaceuticals, Inc.
2022
Loan and Security Agreement, dated February 2, 2022, by and among
Loan Agreements
Tarsus Pharmaceuticals, Inc.
Pharmaceuticals
CA
2022
Consulting Agreement, dated
Consulting Agreements
Tarsus Pharmaceuticals, Inc.
2022
Underwriting Agreement, dated May 2, 2022, by and among the Company, BofA Securities, Inc. and Jefferies LLC
Underwriting Agreements
Tarsus Pharmaceuticals, Inc.
Pharmaceuticals
CA
2022
Description of the Registrants securities registered pursuant to Section 12 of the Securities Exchange Act of 1934
Tarsus Pharmaceuticals, Inc.
2022
Development and license Agreement, between the Registrant and LianBio Ophthalmology, dated as of March, 26, 2021
License Agreements
Tarsus Pharmaceuticals, Inc.
2021
Description of the Registrants securities registered pursuant to Section 12 of the Securities Exchange Act of 1934
Tarsus Pharmaceuticals, Inc.
Pharmaceuticals
2021
Form of Underwriting Agreement
Underwriting Agreements
Tarsus Pharmaceuticals, Inc.
2020
Form of Registrants common stock certificate
Stock Agreements
Tarsus Pharmaceuticals, Inc.
2020
Amended and Restated Investors Rights Agreement, dated September 24, 2020, by and among the Registrant and the other parties thereto
Investor Rights Agreements
Tarsus Pharmaceuticals, Inc.
Pharmaceuticals
DE
2020
Form of Indemnification Agreement between the Registrant and each of its directors and executive officers
Indemnification Agreements
Tarsus Pharmaceuticals, Inc.
Pharmaceuticals
CA
2020
Tarsus Pharmaceuticals, Inc. 2020 Equity Incentive Plan and form of agreements thereunder
Bonus & Incentive Agreements
Tarsus Pharmaceuticals, Inc.
2020
Tarsus Pharmaceuticals, Inc. 2020 Employee Stock Purchase Plan
Stock Agreements
Tarsus Pharmaceuticals, Inc.
2020
Amended and Restated Offer Letter, dated October 8, 2020, between the Registrant and Bobak Azamian, M.D., Ph.D
Tarsus Pharmaceuticals, Inc.
2020
License Agreement, dated January 31, 2019, between the Registrant and Elanco Tiergesundheit AG
License Agreements
Tarsus Pharmaceuticals, Inc.
2020
Amendment to License Agreement, dated September 3, 2020, between the Registrant and Elanco Tiergesundheit AG
License Agreements
Tarsus Pharmaceuticals, Inc.
Pharmaceuticals
2020
License Agreement, dated September 3, 2020, between the Registrant and Elanco Tiergesundheit AG
License Agreements
Tarsus Pharmaceuticals, Inc.
Pharmaceuticals
NY
2020
Management Cash Incentive Plan
Bonus & Incentive Agreements
Tarsus Pharmaceuticals, Inc.
2020
Tarsus Pharmaceuticals, Inc. 2016 Stock Plan, as amended, and forms of agreements thereunder
Stock Agreements
Tarsus Pharmaceuticals, Inc.
Pharmaceuticals
DE
2020
Offer Letter, dated March 15, 2020, between the Registrant and Leo M. Greenstein
Tarsus Pharmaceuticals, Inc.
Pharmaceuticals
2020
Offer Letter, dated June 4, 2020, between the Registrant and Seshadri Neervannan, Ph.D
Tarsus Pharmaceuticals, Inc.
Pharmaceuticals
2020
Offer Letter, dated October 29, 2018, between the Registrant and Mark Holdbrook
Tarsus Pharmaceuticals, Inc.
Pharmaceuticals
CA
2020
Offer Letter, dated June 22, 2020, between the Registrant and Aziz Mottiwala
Tarsus Pharmaceuticals, Inc.
2020
Office Lease, dated May 28, 2020, between the Registrant and Discovery Business Center LLC
Lease Agreements
Tarsus Pharmaceuticals, Inc.
2020
Sublease Agreement, dated May 29, 2020, between the Registrant and Avent, Inc., as amended by First Amendment to Sublease Agreement, dated July 30, 2020, between the Registrant...
Lease Agreements
Tarsus Pharmaceuticals, Inc.
Pharmaceuticals
2020